# US 10,371,661 B2 · Luminescent oxygen channeling immunoassays utilizing electrochemical discharge of singlet oxygen and methods of production and use thereof > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 10,371,661 B2 - Document ID: US10371661B2 - Status: Granted - Kind: B2 - Application number: 14/776,164 - Filed: 2014-03-14 - Published: 2016-02-04 - Granted: 2019-08-06 - Earliest claimed: 2013-03-15 - Assignees: Siemens Healthcare Diagnostics Inc. - Applicants: Siemens Healthcare Diagnostics Inc. - Inventors: David J. Ledden - Web page: https://patentgrep.com/patent/US10371661B2 ## CPC - G01N 27/3275: {Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction} - G01N 21/76: Chemiluminescence; Bioluminescence - G01N 33/542: with steric inhibition or signal modification, e.g. fluorescent quenching - G01N 33/5438: {Electrodes} - G01N 2021/0346: {Capillary cells; Microcells} - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) ## Abstract Chemiluminescent detection systems, kits, and microfluidics devices containing same, as well as methods of production and use thereof, are disclosed. ## Claims ### Claim 1 A kit containing a chemiluminescent detection system for use with an instrument system, the chemiluminescent detection system comprising: (a) an electrode that specifically binds (directly or indirectly) to a target analyte, wherein the electrode has a potential applied thereto and generates singlet oxygen in its excited state; (b) a composition comprising a singlet oxygen-activatable chemiluminescent compound capable of directly or indirectly binding to the target analyte; and (c) a composition comprising a singlet oxygen generator; (d) a microfluidics device in which (a), (b), and (c) are disposed; and wherein application of the potential to (a) by the instrument system and in the presence of (c) causes generation of singlet oxygen in the absence of a light source, and wherein the singlet oxygen reacts with (b), thus generating a detectable amount of chemiluminescence; and wherein the electrode is disposed in a read chamber of the microfluidics device, and wherein the read chamber can be interrogated by the instrument system for detecting the amount of chemiluminescence produced. ### Claim 2 (depends on 1) The kit of claim 1, wherein at least a portion of a surface of the electrode is provided with a streptavidin coating disposed thereon, and wherein biotin is associated with a first analyte-specific binding partner, whereby the binding of streptavidin and biotin and the binding of the first analyte-specific binding partner to the target analyte results in the indirect association of the electrode to the target analyte. ### Claim 3 (depends on 1) The kit of claim 1, wherein the composition comprising the singlet oxygen-activatable chemiluminescent compound has a second analyte specific binding partner associated therewith that allows for the indirect association of the chemiluminescent compound to the target analyte. ### Claim 4 (depends on 1) The kit of claim 1, wherein the composition comprising the the singlet oxygen-activatable chemiluminescent compound further comprises at least one fluorescent molecule that is excited by the singlet oxygen-activatable chemiluminescent compound. ### Claim 5 (depends on 1) The kit of claim 1, wherein the electrode and the composition comprising the singlet oxygen-activatable chemiluminescent compound has target analyte or an analog thereof attached thereto. ### Claim 6 A microfluidics device for disposal within an instrument system, the microfluidics device comprising: (a) an inlet channel through which a sample is applied; (b) at least one compartment capable of being in fluidic communication with the inlet channel, the at least one compartment containing: (i) an electrode that specifically binds (directly or indirectly) to a target analyte, wherein the electrode has a potential applied thereto and generates singlet oxygen in its excited state; (ii) a composition comprising a singlet oxygen-activatable chemiluminescent compound capable of directly or indirectly binding to the target analyte; and (iii) a composition comprising a singlet oxygen generator; and wherein application of a potential to (i) by the instrument system and in the presence of (iii) causes generation of singlet oxygen in the absence of a light source, and wherein the singlet oxygen reacts with (ii), thus generating a detectable amount of chemiluminescence; and wherein the electrode is disposed in a read chamber, and wherein the read chamber can be interrogated by the instrument system for detecting the amount of chemiluminescence produced. ### Claim 7 (depends on 6) The microfluidics device of claim 6, wherein one of: (a) the electrode has target analyte or an analog thereof attached thereto, whereby the composition comprising the singlet oxygen-activatable chemiluminescent compound is capable of directly or indirectly binding to target analyte present in a sample or to target analyte or analog thereof attached to the electrode; and (b) the composition comprising the singlet oxygen-activatable chemiluminescent compound has target analyte or an analog thereof attached thereto, whereby the electrode is capable of directly or indirectly binding to target analyte present in a sample or to target analyte or analog thereof attached to the composition comprising the singlet oxygen-activatable chemiluminescent compound. ### Claim 8 (depends on 6) The microfluidics device of claim 6, wherein (ii) and/or (iii) are disposed in at least one other compartment that is different from a compartment containing (i), and wherein the compartment containing (i) and the at least one other compartment containing (ii) and/or (iii) are capable of being in fluidic communication with one another. ### Claim 9 (depends on 6) The microfluidics device of claim 6, wherein at least one of the composition of (ii) or (iii) is lyophilized. ### Claim 10 (depends on 9) The microfluidics device of claim 9, further comprising at least one additional compartment capable of being in fluidic communication with at least one other compartment, wherein the at least one additional compartment contains an excipient for reconstitution of the at least one lyophilized reagent. ### Claim 11 (depends on 6) The microfluidics device of claim 6, wherein at least a portion of a surface of the electrode is provided with a streptavidin coating disposed thereon, and wherein biotin is associated with a first analyte-specific binding partner, whereby the binding of streptavidin and biotin and the binding of the first analyte-specific binding partner to the target analyte results in the indirect association of the electrode to the target analyte. ### Claim 12 A method for detecting the presence and/or concentration of a target analyte in a sample, comprising the steps of: (a) combining, either simultaneously or wholly or partially sequentially: (1) a sample suspected of containing the target analyte; (2) an electrode capable of directly or indirectly binding to the target analyte and capable of generating singlet oxygen in its excited state; and (3) a composition comprising a singlet oxygen-activatable chemiluminescent compound capable of directly or indirectly binding to the target analyte; (b) allowing the binding of the composition comprising the chemiluminescent compound and the electrode to the target analyte, whereby a sandwich complex is formed by the binding of (2) and (3) to the target analyte such that the electrode is brought into close proximity to the chemiluminescent compound; (c) washing the electrode with a composition comprising a singlet oxygen generator; (d) applying a potential to the electrode to generate singlet oxygen, wherein generation of singlet oxygen in close proximity to the chemiluminescent compound causes the activation of the chemiluminescent compound present in the sandwich complex, thus generating a detectable signal in the absence of a light source; (e) determining the amount of chemiluminescence generated by the activated chemiluminescent compound; (f) optionally repeating steps (b)-(e); and (g) detecting the presence and/or concentration of the target analyte by analyzing the amount of chemiluminescence so produced, wherein the amount of chemiluminescence is directly proportional to the amount of target analyte in the sample. ### Claim 13 (depends on 12) The method of claim 12, wherein at least a portion of a surface of the electrode is provided with a streptavidin coating disposed thereon, and wherein biotin is associated with a first analyte-specific binding partner, whereby the binding of streptavidin and biotin and the binding of the first analyte-specific binding partner to the target analyte results in the indirect association of the electrode to the target analyte. ### Claim 14 (depends on 12) The method of claim 12, wherein the composition comprising the singlet oxygen-activatable chemiluminescent compound has a second analyte-specific binding partner associated therewith that allows for the indirect association of the chemiluminescent compound to the target analyte. ### Claim 15 (depends on 12) The method of claim 12, wherein the singlet oxygen-activatable chemiluminescent compound is a substance that undergoes a chemical reaction with singlet oxygen to form a metastabile intermediate species that can decompose with the simultaneous or subsequent emission of light. ### Claim 16 (depends on 12) The method of claim 12, further comprising the step of substantially washing away unbound or non-specifically bound (1) and (3) compositions from the electrode after step (b). ### Claim 17 (depends on 12) The method of claim 12, wherein the composition comprising the chemiluminescent compound further comprises at least one fluorescent molecule that is excited by the activated chemiluminescent compound.